Literature DB >> 11422486

Immunohistochemistry and the diagnosis of malignant mesothelioma.

J E King1, P S Hasleton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11422486     DOI： 10.1046/j.1365-2559.2001.01092.x

Source DB:  PubMed          Journal:  Histopathology        ISSN： 0309-0167            Impact factor:   5.087


× No keyword cloud information.
  4 in total

1.  Establishment of permanent cell lines purified from human mesothelioma: morphological aspects, new marker expression and karyotypic analysis.

Authors:  Marie-Marthe Philippeaux; Jean-Claude Pache; Sophie Dahoun; Marc Barnet; John-Henri Robert; Jacques Mauël; Anastase Spiliopoulos
Journal:  Histochem Cell Biol       Date:  2004-09-15       Impact factor: 4.304

2.  BTS statement on malignant mesothelioma in the UK, 2007.

Authors: 
Journal:  Thorax       Date:  2007-11       Impact factor: 9.139

3.  Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies.

Authors:  A S Abutaily; B J Addis; W R Roche
Journal:  J Clin Pathol       Date:  2002-09       Impact factor: 3.411

4.  Asbestos-induced peritoneal mesothelioma in a construction worker.

Authors:  Rodolfo Fonte; Salvatore Gambettino; Mario Melazzini; Mario Scelsi; Claudio Zanon; Stefano M Candura
Journal:  Environ Health Perspect       Date:  2004-04       Impact factor: 9.031
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.